Figure 8.
The expressions of four signature genes were validated by quantitative real-time PCR (qRT-PCR). *P< 0.05; **P< 0.01; ***P< 0.001; ns, no significance. (A) The expression of TUBB4A in DLBCL patients. (B) The expression of TEX9 in DLBCL patients. (C) The expression of SLC38A5 in DLBCL patients. (D) The expression of S100B in DLBCL patients.
